Partner

At a glance

1

Finished Products

1

Therapy Areas

2+

Delivery Formats

C3-CURA™

Primary Platform

All ingredients
Corn SilkIngredient · 09/14

Corn Silk

Glycosylated flavone – Corn Silk

Market Landscape

The opportunity – and where the market falls short.

  • 01Natural diuretic – urine flow, fluid balance, urinary health
  • 02Targeted benefits – UTIs, kidney support, inflammation, metabolic
  • 03Traditional relevance with modern use
  • 04Emerging opportunity in urology and metabolic health
  • 05Niche market with limited capsule/tea formats
The Stabicon Edge

From market limitation to measurable transformation.

Market LimitationStabicon TransformationImpact
Low AwarenessTargeted Health PositioningRecognition as a functional urology ingredient
Limited Clinical PositioningCondition-Led Approach – UTI, fluid retention, kidney, weightStronger relevance
Traditional Formats OnlyMulti-Format Delivery – sachets, liquids, tablets, blendsWider consumer reach
Lack of StandardizationStandardized ExtractsConsistent efficacy and quality
No Format InnovationModern Delivery SystemsBetter differentiation
Untapped Preventive SegmentDaily Urinary Health PlatformRepeat-use preventive portfolio
Stabicon's Portfolio

Corn Silk reimagined across therapy areas and delivery formats.

1 finished formulation powered by Corn Silk, organised across 1 therapy category.

01

Products

01

Therapy Areas

02+

Formats

Stabicon Life Sciences

Science-Led Formulations. Scalable Health Platforms.

Offices

Corporate Office

22, 7th Cross, Jaibharath Nagar, Bengaluru 560 033, Karnataka, India

Research & Development

28, Bommasandra Industrial Area, 4th Phase, Jigani Hobli, Anekal Taluk, Bengaluru 560 099, Karnataka, India

Newsletter

Quarterly briefings on platforms, science & partnerships.

No spam. Unsubscribe in one click. Your email stays with us.

Press Kit

Logos, fact sheet & spokesperson bios – all in one download.

Download Press Kit (ZIP)

For media queries: press@stabicon.com

Accreditations

ISO/IEC 17025:2017 (NABL)WHO Geneva – Audited & ApprovedFSSAI ApprovedCDSCO IndiaUS FDA – Registered FacilityDSIR RegisteredAYUSH Registered

© 2026 Stabicon Life Sciences Pvt. Ltd. All rights reserved.

Science-Led Formulations. Scalable Health Platforms.